Retina CRO niche CTRG specializes in ophthalmology clinical trials as a full-capacity CRO with retina-specific guidance, presenting an opportunity to position related services such as study design optimization, regulatory strategy, and investigator engagement tailored to eye health trials.

Mid-market traction With 11-50 employees and annual revenue in the 1M-10M range, CTRG is a growing mid-market CRO that could benefit from scalable services like modular CRO processes, vendor management, and remote monitoring offerings that align with lean sponsor needs.

Expanding capabilities The shift from SMO to a full CRO indicates appetite for end-to-end trial support; sales opportunities exist in expanding services such as data management, biostatistics, medical writing, and regulatory submissions to cover all trial phases.

Tech stack ready Adoption of Microsoft 365 and external network hosting suggests openness to modernization; opportunities exist to propose integrated EDC, risk-based monitoring, cloud-enabled collaboration tools, and secure data workflows to boost efficiency.

Partner with sponsors As a trusted independent partner for sponsors developing ophthalmology therapies and devices, CTRG is well-positioned to pursue strategic collaborations, co-development of trial programs, and preferred provider agreements with mid-to-large pharma and medical device sponsors.